Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
QingSong HealthHKSE:02661 -2.20%18 EPS without NRI is HK$-2.62 as of Jun. 2026. GuruFocus rates HKSE:02661 with a GF Score™ of 18/100. The stock has 4 warning signs investors should review. Among 502 Healthcare Providers & Services companies, QingSong Health ranks worse than 99.6% on this metric.
QingSong Health's earnings per share without non-recurring items for the
six
months ended in Jun. 2026 was HK$-0.29.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2026 was HK$-2.62.
During the past 12 months, QingSong Health's average earnings per share (NRI) Growth Rate was -605.20% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was -303.00% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for QingSong Health's EPS without NRI or its related term are showing as below:
HKSE:02661'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -303 Med: -303 Max: -303
Current: -303
During the past 4 years, QingSong Health's highest 3-Year average Earnings Per Share (NRI) Growth Rate was -303.00% per year. The lowest was -303.00% per year. And the median was -303.00% per year.
HKSE:02661's 3-Year EPS without NRI Growth Rate is ranked worse than 99.6% of 502
companies
in the Healthcare Providers & Services industry
Industry Median: 10.7
vs HKSE:02661: -303.00
QingSong Health's EPS (Diluted) for the
six
months ended in Jun. 2026 was HK$-0.29.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was HK$-2.78.
QingSong Health's EPS (Basic) for the
six
months ended in Jun. 2026 was HK$-0.29.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2026 was HK$-2.78.
QingSong Health (HKSE:02661) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
QingSong Health EPS without NRI Related Terms
QingSong Health EPS without NRI Historical Data
* Premium members only.
The historical data trend for QingSong Health's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02661 vs VEEV, BTSG, TEM: EPS without NRI Comparison
For the Health Information Services subindustry, QingSong Health's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
QingSong Health PE Ratio without NRI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, QingSong Health's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where QingSong Health's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-2.62
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
QingSong Health (HKSE:02661) has a EPS without NRI of HK$-2.62 as of Jun. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on QingSong Health and its competitors. According to the industry distribution chart, QingSong Health ranks #500 out of 502 companies in the Healthcare Providers & Services industry, placing it in the top 99.6%.
Is QingSong Health's EPS without NRI too high?
QingSong Health's current EPS without NRI is HK$-2.62. Based on the distribution chart, QingSong Health ranks #500 out of 502 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, QingSong Health has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does QingSong Health's EPS without NRI compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, QingSong Health ranks #500 out of 502 companies for EPS without NRI. This places QingSong Health in the lower half of its industry. The industry median EPS without NRI is 10.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Healthcare Providers & Services company?
The median EPS without NRI among Healthcare Providers & Services companies is 10.70, based on 502 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on QingSong Health and its competitors. For the Healthcare Providers & Services industry, the median EPS without NRI is 10.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. QingSong Health's current EPS without NRI is HK$-2.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QingSong Health stock overvalued right now?
QingSong Health (HKSE:02661) has a current EPS without NRI of HK$-2.62. The current EPS without NRI is HK$-2.62. QingSong Health's overall GF Score™ is 18/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For QingSong Health (HKSE:02661), the current EPS without NRI is HK$-2.62 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
QingSong Health Corp is a technology-driven one-stop platform in China, focusing on providing comprehensive health services and health insurance solutions. It offers healthcare-related services, including early disease screening promotion and consultancy, health examinations and consultations, medical appointment services, and the sale of health supplements. It prominently offers health insurance products providing coverage for illness and medical expenses, typically for one year or less. The company also offers critical illness insurance, which provides a lump-sum payment if the policyholder is diagnosed with specified serious illnesses. It derives revenue from the provision of Healthcare-related Services. Geographically, it operates only in China.
18GF Score
Get the complete analysis for HKSE:02661
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02661 has been successfully added to your 
